Form 8-K - Current report:
SEC Accession No. 0001615774-16-008137
Filing Date
2016-11-10
Accepted
2016-11-10 07:05:27
Documents
5
Period of Report
2016-11-10
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K s104619_8k.htm 8-K 21971
2 EXHIBIT 99-01 s104619_ex99-01.htm EX-99.01 878
3 EXHIBIT 99-02 s104619_ex99-02.htm EX-99.02 11655
4 GRAPHIC pg1img1_ex99-01.jpg GRAPHIC 12655599
5 GRAPHIC pg1img1_ex99-02.jpg GRAPHIC 11496
  Complete submission text file 0001615774-16-008137.txt   17467086
Mailing Address 509 MADISON AVE. - SUITE 306 NEW YORK NY 10022
Business Address 509 MADISON AVE. - SUITE 306 NEW YORK NY 10022 1-800-849-7894
Tonix Pharmaceuticals Holding Corp. (Filer) CIK: 0001430306 (see all company filings)

IRS No.: 261434750 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36019 | Film No.: 161985959
SIC: 2834 Pharmaceutical Preparations